Institutional Ownership Protagonist Therapeutics, Inc (PTGX)
This table provides information about the institutional ownership of Protagonist Therapeutics, Inc (PTGX). We have compiled data on the 248 institutions that hold shares in the stock, with a total of 56.7 Million shares, which have been reported (via 13F filing form) to have a value of $2.3 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Mangrove Partners
New York, NY |
Nov 14, 2024 Q3 2024 |
439,314
shares
|
$17.3 Million
2.57% of portfolio
|
Q3 2023
New holding
|
|
683 Capital Management, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
420,000
shares
|
$16.5 Million
1.72% of portfolio
|
Q3 2024
Reduced 30.52%
|
|
Gratus Capital LLC
|
Jul 25, 2024 Q2 2024 |
418,346
shares
|
$16.4 Million
0.61% of portfolio
|
Q2 2024
Added 2.49%
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2024 Q3 2024 |
368,132
shares
|
$14.5 Million
0.0% of portfolio
|
Q3 2024
Reduced 0.49%
|
|
Polar Capital Holdings PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
350,000
shares
|
$13.8 Million
0.1% of portfolio
|
Q3 2024
New holding
|
|
Cowen And Company, LLC
|
Nov 12, 2024 Q3 2024 |
340,974
shares
|
$13.4 Million
0.39% of portfolio
|
Q3 2024
Reduced 71.16%
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2024 Q3 2024 |
322,989
shares
|
$12.7 Million
0.02% of portfolio
|
Q3 2024
Reduced 28.72%
|
|
Principal Financial Group Inc
Des Moines, IA |
Dec 19, 2024 Q3 2024 |
320,832
shares
|
$12.6 Million
0.87% of portfolio
|
Q3 2024
New holding
|
|
Marshall Wace, LLP
London, X0 |
Nov 14, 2024 Q3 2024 |
315,373
shares
|
$12.4 Million
0.02% of portfolio
|
Q3 2024
Reduced 44.88%
|
|
Eagle Asset Management Inc
St Petersburg, FL |
Nov 12, 2024 Q3 2024 |
294,280
shares
|
$11.6 Million
0.08% of portfolio
|
Q3 2024
Reduced 17.71%
|
|
Kennedy Capital Management, Inc.
St Louis, MO |
Nov 14, 2024 Q3 2024 |
267,033
shares
|
$10.5 Million
0.28% of portfolio
|
Q3 2024
Reduced 7.95%
|
|
Checkpoint Capital L.P.
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
240,000
shares
|
$9.43 Million
5.36% of portfolio
|
Q3 2024
Reduced 32.39%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
232,074
shares
|
$9.12 Million
0.0% of portfolio
|
Q3 2024
Reduced 37.95%
|
|
Skandinaviska Enskilda Banken Ab (Publ)
Stockholm, V7 |
Nov 07, 2024 Q3 2024 |
230,114
shares
|
$9.04 Million
0.05% of portfolio
|
Q3 2024
Added 1116.63%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 07, 2024 Q3 2024 |
225,589
shares
|
$8.87 Million
0.0% of portfolio
|
Q3 2024
Reduced 63.39%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Nov 14, 2024 Q3 2024 |
214,872
shares
|
$8.44 Million
0.03% of portfolio
|
Q3 2024
Reduced 76.38%
|
|
Td Asset Management Inc
|
Nov 01, 2024 Q3 2024 |
172,202
shares
|
$6.77 Million
0.01% of portfolio
|
Q3 2024
Added 16.12%
|
|
Rhumbline Advisers
Boston, MA |
Nov 12, 2024 Q3 2024 |
164,178
shares
|
$6.45 Million
0.01% of portfolio
|
Q3 2024
Added 93.21%
|
|
Candriam S.C.A.
|
Nov 13, 2024 Q3 2024 |
162,492
shares
|
$6.39 Million
0.04% of portfolio
|
Q3 2024
Reduced 40.66%
|
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
Nov 14, 2024 Q3 2024 |
158,067
shares
|
$6.21 Million
0.01% of portfolio
|
Q3 2024
New holding
|
|
Legal & General Group PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
157,414
shares
|
$6.19 Million
0.0% of portfolio
|
Q3 2024
Added 164.4%
|
|
Rothschild & CO Asset Management Us Inc.
New York, NY |
Feb 14, 2023 Q4 2022 |
153,294
shares
|
$6.02 Million
0.03% of portfolio
|
Q4 2022
Reduced 0.77%
|
|
Silverarc Capital Management, LLC
|
Nov 14, 2024 Q3 2024 |
146,657
shares
|
$5.76 Million
1.64% of portfolio
|
Q3 2024
New holding
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
144,167
shares
|
$5.67 Million
0.01% of portfolio
|
Q3 2024
Reduced 51.54%
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Nov 14, 2024 Q3 2024 |
143,807
shares
|
$5.65 Million
0.0% of portfolio
|
Q3 2024
New holding
|